Although the popular opioid, tramadol, may reduce chronic pain, it also significantly increases risk of serious side effects ...

An analysis prompted the researchers to conclude that “the potential harms of tramadol probably outweigh its benefits”. It also suggested that tramadol's use should be minimised.

A BMJ review finds tramadol offers minimal chronic pain relief but significantly increases serious side effects, especially heart-related risks.

Tramadol, a default in clinics and home cabinets nationwide, long seen as gentler than other opioids; fresh analysis ...

A recent study revealed that Tramadol, which is widely known to be a "safer" painkiller, might not be as beneficial. A large analysis of clinical trials found that the painkiller might help reduce ...

Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of clinical trials found that while it does reduce chronic pain, the relief is modest ...

Tramadol is widely prescribed for chronic pain, but a new review suggests the relief is modest and the risks may be greater than many realize.

New research indicates tramadol offers minimal pain relief, lowering scores by less than one point on average. The drug significantly increases the risk of serious side effects, particularly heart ...

Danish researchers conducted a review of previous clinical trials and found the drug provides minimal pain relief while more than doubling a patient's overall risk of deadly cardiac effects.

CHATHAM, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix” or the "Company”), a fully-integrated commercial stage biotechnology company, today ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Fever, chills, sore throat, cough… the list of common flu symptoms goes on. Fortunately, the antiviral drug Tamiflu ...